Can Traditional CER Address Resource Allocation?

While the growth in U.S. healthcare costs is receiving substantial attention, many believe that instead of looking at general contributors, i.e. pharmaceutical pricing, we should look to resource allocation. Could Comparative Effectiveness Research (CER) methods help to answer this or is something different needed? Learn more here. (Source: Robert W Dubois, Future Medicine, Nov 2016)

You might also be interested in:

ISPOR Europe 2019 to Focus on Digital Transformation of Health Care 10/23/2019
Stanford Center for Health Education Launches Online Program… 08/11/2020
Toward A More Precise Public Health Strategy in the Battle… 08/13/2020
Dubois: It's Time to Talk COVID-19 Prices 05/28/2020
The Professional Society for Health Economics and Outcomes… 08/18/2020
Invoke a 1980's Law to Lower Cost of Remdesivir for COVID-19,… 08/07/2020
NPC's Dubois: ICER Changes Benefit Payers, Not Patients 10/04/2019